Analyst Price Targets — BIOX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 2, 2026 11:24 am | Austin Moeller | Canaccord Genuity | $2.00 | $1.31 | TheFly | Bioceres price target lowered to $2 from $2.25 at Canaccord |
| September 10, 2025 12:24 pm | Ben Klieve | Lake Street | $5.00 | $2.06 | TheFly | Bioceres price target lowered to $5 from $8 at Lake Street |
| September 10, 2025 9:01 am | — | Canaccord Genuity | $2.50 | $2.06 | TheFly | Bioceres downgraded to Hold from Buy at Canaccord |
| September 9, 2025 6:40 pm | — | Oppenheimer | $5.00 | $2.24 | StreetInsider | Bioceres Crop Solutions (BIOX) PT Lowered to $5 at OppenheimerMember Login |
| October 21, 2024 7:33 am | Kristen Owen | Oppenheimer | $13.00 | $7.51 | StreetInsider | Bioceres Crop Solutions (BIOX) PT Lowered to $13 at Oppenheimer |
| September 11, 2024 8:17 am | Ben Klieve | Loop Capital Markets | $13.00 | $8.31 | StreetInsider | Bioceres Crop Solutions (BIOX) PT Lowered to $13 at Lake Street Capital Markets |
| September 11, 2024 8:01 am | Ben Klieve | Lake Street | $13.00 | $8.65 | TheFly | Bioceres price target lowered to $13 from $25 at Lake Street |
| September 11, 2024 6:57 am | Austin Moeller | Canaccord Genuity | $12.50 | $8.36 | StreetInsider | Bioceres Crop Solutions (BIOX) PT Lowered to $12.50 at Canaccord Genuity |
| September 10, 2024 4:03 pm | Kristen Owen | Oppenheimer | $16.00 | $8.65 | StreetInsider | Bioceres Crop Solutions (BIOX) PT Lowered to $16 at Oppenheimer |
| July 2, 2024 7:40 am | Scott Fortune | Roth Capital | $15.00 | $11.13 | TheFly | Bioceres resumed with a Buy at Roth MKM |
Latest News for BIOX
Bioceres Crop Solutions Corp. (NASDAQ: BIOX - Get Free Report) saw a large growth in short interest during the month of February. As of February 13th, there was short interest totaling 942,815 shares, a growth of 71.0% from the January 29th total of 551,455 shares. Approximately 1.5% of the company's shares are sold short. Based on
Bioceres Crop Solutions Corp. (NASDAQ: BIOX - Get Free Report) has earned a consensus recommendation of "Hold" from the five analysts that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the company.
Bioceres Crop Solutions Corp. (BIOX) Shareholder/Analyst Call Prepared Remarks Transcript
Bioceres Crop Solutions Corp. (NASDAQ: BIOX - Get Free Report) has received a consensus recommendation of "Hold" from the five research firms that are covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and one has assigned a buy recommendation to the company.
Bioceres Crop Solutions (NASDAQ: BIOX - Get Free Report) and Brasilagro Cia Brasileira De Propriedades Agricolas (NYSE: LND - Get Free Report) are both small-cap consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, dividends, analyst recommendations, profitability and earnings. Earnings
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for BIOX.
Senate Trading
No Senate trades found for BIOX.
U.S. House Trading
No House trades found for BIOX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.